Belmont Capital’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Hold |
40,000
| – | – | 0.08% | 70 |
|
|
2025
Q1 | $424K | Hold |
40,000
| – | – | 0.08% | 77 |
|
|
2024
Q4 | $679K | Hold |
40,000
| – | – | 0.11% | 42 |
|
|
2024
Q3 | $928K | Hold |
40,000
| – | – | 0.15% | 47 |
|
|
2024
Q2 | $974K | Hold |
40,000
| – | – | 0.18% | 47 |
|
|
2024
Q1 | $1.35M | Buy |
+40,000
| New | +$1.35M | 0.37% | 30 |
|